We are live on
!
Find out more
OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
124.8%
This Fund
S&P 500
This Quarter
Est. Return
+16.07%
1 Year Est. Return
+124.8%
3 Year Est. Return
+486.05%
5 Year Est. Return
+742.19%
10 Year Est. Return
+62,231.09%
AUM
$758M
AUM Growth
+$50.6M
(+7.1%)
Cap. Flow
+$32.3M
Cap. Flow
% of AUM
4.26%
Top 10 Holdings %
Top 10 Hldgs %
65.47%
Holding
64
New
21
Increased
16
Reduced
8
Closed
9
Top Buys
| 1 |
Rezolute
RZLT
|
+$42.2M |
| 2 |
CBIO
Crescent Biopharma
CBIO
|
+$15M |
| 3 |
ACOG
Alpha Cognition
ACOG
|
+$12.4M |
| 4 |
Sol-Gel Technologies
SLGL
|
+$9.61M |
| 5 |
UroGen Pharma
URGN
|
+$5.82M |
Top Sells
| 1 |
Immunome
IMNM
|
+$37.3M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
+$14M |
| 3 |
Codexis
CDXS
|
+$12.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$11.3M |
| 5 |
Larimar Therapeutics
LRMR
|
+$10.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$1.55B
| $191M | 25.25% |
3,905,000
| – | – |
|
2
Liquidia Corp
LQDA
$6.75B
| $85M | 11.21% |
2,435,000
-180,000
| -7% | -$5.12M |
|
3
Eton Pharmaceutcials
ETON
$1.03B
| $48.4M | 6.38% |
2,860,000
| – | – |
|
|
4
Rhythm Pharmaceuticals
RYTM
$7.49B
| $35.3M | 4.66% |
330,000
-131,700
| -29% | -$14M |
|
5
Apogee Therapeutics
APGE
$10.1B
| $29.3M | 3.87% |
388,257
+25,000
| +7% | +$1.57M |
|
|
SNWV
6
SANUWAVE Health Inc
SNWV
$103M
| $29.3M | 3.86% |
981,267
+1,267
| +0.1% | +$40.6K |
|
7
Stoke Therapeutics
STOK
$1.82B
| $22.1M | 2.91% |
695,000
+12,983
| +2% | +$390K |
|
8
Ocular Therapeutix
OCUL
$2.14B
| $19.4M | 2.55% |
1,595,000
| – | – |
|
|
9
Sol-Gel Technologies
SLGL
$243M
| $19.1M | 2.52% |
453,739
+248,904
| +122% | +$9.61M |
|
10
CG Oncology
CGON
$6.29B
| $17M | 2.25% |
410,000
| – | – |
|
11
TG Therapeutics
TGTX
$8.45B
| $15.9M | 2.1% |
535,000
| – | – |
|
12
Disc Medicine
IRON
$2.86B
| $15.9M | 2.1% |
200,000
+6,227
| +3% | +$526K |
|
|
13
Rezolute
RZLT
$465M
| $14.8M | 1.96% |
6,287,156
+5,383,714
| +596% | +$42.2M |
|
|
CBIO
14
Crescent Biopharma
CBIO
$438M
| $14M | 1.84% |
+1,178,300
| New | +$15M |
|
15
Alkermes
ALKS
$8.46B
| $13.7M | 1.81% |
490,000
+40,000
| +9% | +$1.2M |
|
|
ACOG
16
Alpha Cognition
ACOG
$174M
| $13.5M | 1.78% |
2,070,784
+1,955,642
| +1,698% | +$12.4M |
|
17
Annexon
ANNX
$914M
| $13.1M | 1.72% |
2,600,000
| – | – |
|
18
Edgewise Therapeutics
EWTX
$4.29B
| $12.4M | 1.64% |
500,000
| – | – |
|
|
19
Codexis
CDXS
$199M
| $11.1M | 1.46% |
6,789,738
-6,005,262
| -47% | -$12.2M |
|
20
Protagonist Therapeutics
PTGX
$8.31B
| $9.17M | 1.21% |
105,000
| – | – |
|
21
Gossamer Bio
GOSS
$64.9M
| $8.43M | 1.11% |
2,720,000
-5,000
| -0.2% | -$14.3K |
|
|
MBX
22
MBX Biosciences
MBX
$2.66B
| $8.2M | 1.08% |
260,000
+7,000
| +3% | +$170K |
|
23
Revolution Medicines
RVMD
$39.3B
| $7.96M | 1.05% |
100,000
| – | – |
|
24
Xoma
XOMA
$710M
| $7.78M | 1.03% |
292,590
+37,503
| +15% | +$1.21M |
|
25
Journey Medical
DERM
$194M
| $7.52M | 0.99% |
975,000
+3,936
| +0.4% | +$30.9K |
|
Similar funds
WCFA
SIG
GWM
IAS
TVAMP
RFM
MWA
CFS